Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psychobiology and Treatment of Primary Insomnia
NCT00177216Phase 4Completed
- Sponsor
- University of Pittsburgh
- Start
- Feb 2002
- Primary completion
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of zolpidem sublingual tablet and Escitalopram oxalate oral solution in Insomnia (3 arms), sponsored by University of Pittsburgh. Primary endpoints: Change in Pittsburgh Sleep Quality Index at 100 days and Change in Diary Sleep Efficiency at 69 days. Started Feb 2002; status: completed.
02
Drugs
zolpidem sublingual tabletEscitalopram oxalate oral solution
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT00177216.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00177216.